Candel Therapeutics, Inc. — All Filings
371 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0000950170-25-087703 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-087705 | Jun 18, 2025 | Jun 17, 2025 |
| 4 | 4 | 0000950170-25-083163 | Jun 6, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0000950170-25-082705 | Jun 6, 2025 | Jun 4, 2025 |
| 3 | 3 | 0000950170-25-083136 | Jun 6, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0000950170-25-078079 | May 28, 2025 | — |
| 8-K | 8-K | 0000950170-25-076458 | May 22, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-049512 | May 15, 2025 | — |
| 8-K | 8-K | 0000950170-25-069826 | May 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-069833 | May 13, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-060093 | Apr 29, 2025 | Jun 17, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-060112 | Apr 29, 2025 | — |
| ARS | ARS | 0000950170-25-060171 | Apr 29, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-057398 | Apr 23, 2025 | — |
| 8-K | 8-K | 0001193125-25-064374 | Mar 27, 2025 | Mar 26, 2025 |
| 4/A | 4/A | 0000950170-25-042724 | Mar 20, 2025 | Mar 17, 2025 |
| 4 | 4 | 0000950170-25-042725 | Mar 20, 2025 | Mar 18, 2025 |
| 4 | 4 | 0000950170-25-042726 | Mar 20, 2025 | Mar 18, 2025 |
| 4 | 4 | 0000950170-25-042728 | Mar 20, 2025 | Mar 18, 2025 |
| 4 | 4 | 0000950170-25-041991 | Mar 19, 2025 | Mar 17, 2025 |
| 4 | 4 | 0000950170-25-042002 | Mar 19, 2025 | Mar 17, 2025 |
| 144 | — | 0001950047-25-002014 | Mar 18, 2025 | — |
| 144 | — | 0001950047-25-002013 | Mar 18, 2025 | — |
| 144 | — | 0001950047-25-002010 | Mar 18, 2025 | — |
| 144 | — | 0001950047-25-001942 | Mar 17, 2025 | — |
| 144 | — | 0001950047-25-001943 | Mar 17, 2025 | — |
| S-8 | S-8 | 0001193125-25-053987 | Mar 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-038757 | Mar 13, 2025 | — |
| 10-K | 10-K | 0000950170-25-038803 | Mar 13, 2025 | Dec 31, 2024 |
| 4 | PRIMARY DOCUMENT | 0001873919-25-000002 | Feb 25, 2025 | Feb 21, 2025 |
| 8-K | 8-K | 0000950170-25-026100 | Feb 25, 2025 | — |
| 4 | 4 | 0000950170-25-021284 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | 4 | 0000950170-25-021287 | Feb 14, 2025 | Feb 12, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-004195 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-014091 | Feb 14, 2025 | — |
| 4 | 4 | 0000950170-25-021282 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | 4 | 0000950170-25-021283 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | 4 | 0000950170-25-021292 | Feb 14, 2025 | Feb 12, 2025 |
| 4 | PRIMARY DOCUMENT | 0001873919-25-000001 | Feb 13, 2025 | Feb 10, 2025 |
| SCHEDULE 13G | — | 0000315066-25-000400 | Feb 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000411 | Feb 7, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000036 | Feb 7, 2025 | — |
| 4 | 4 | 0000950170-25-006726 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | 4 | 0000950170-25-006723 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | 4 | 0000950170-25-006724 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | 4 | 0000950170-25-006725 | Jan 17, 2025 | Jan 15, 2025 |
| 4 | 4 | 0000950170-25-006733 | Jan 17, 2025 | Jan 15, 2025 |
| 144 | — | 0000950170-25-005637 | Jan 15, 2025 | — |
| 144 | — | 0000950170-25-005638 | Jan 15, 2025 | — |
| 144 | — | 0000950170-25-005639 | Jan 15, 2025 | — |